Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis
about
sameAs
Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@ast
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@en
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@nl
type
label
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@ast
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@en
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@nl
prefLabel
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@ast
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@en
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@nl
P2093
P2860
P50
P1476
Drugs for cardiovascular disea ...... lopment-a qualitative analysis
@en
P2093
Charles Newman
Ravi Srinivas
Sandeep Bhalla
P2860
P2888
P356
10.1186/S40545-016-0065-7
P407
P577
2016-05-02T00:00:00Z
P6179
1031860884